Join
Live feed
·
PRReleasevia Quantisnow
Kezar Life Sciences Inc. logo

Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences

ByQuantisnow·Wall Street's wire, on your screen.
KZR· Kezar Life Sciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KZR (Kezar Life Sciences Inc.) and more on Quantisnow.